T1487

Fluvastatin sodium (Fluvastatin sodium salt), a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR), is a commonly used cholesterol lowering agent.

Carboxyamidotriazole Orotate (L-651582 Orotate) is a cytostatic inhibitor of non-voltage-operated calcium channels and associated signaling pathways. As the orotate salt form of Carboxyamidotriazole (CAI), it is an orally bioavailable signal transduction inhibitor with in vitro antileukaemic activity, exhibiting anti-tumor, anti-inflammatory, and antiangiogenic effects.

Carboxy-PEG5-sulfonic acid, a PEG-based PROTAC linker, is utilized for the synthesis of PROTACs[1].

Carboxyamidotriazole is a cytostatic inhibitor of non-voltage-operated calcium channels and calcium channel-mediated signaling pathways. It shows anti-inflammatory, anti-tumor, and antiangiogenic effects.

Carboxyrhodamine 110-PEG3-Azide is a polyethylene glycol (PEG)-based linker utilized for the synthesis of Proteolysis Targeting Chimeras (PROTACs) [1].

Carboxyrhodamine 110-PEG4-alkyne is a polyethylene glycol (PEG) derived linker utilized in the synthesis of proteolysis-targeting chimeras (PROTACs)[1].

Carotegrast is a selective α4 integrin antagonist that inhibits the migration of inflammatory cells to the intestinal mucosa by blocking the interaction between α4β1/α4β7 integrins and their ligands. Carotegrast is used in research and clinical practice for the treatment of inflammatory bowel diseases such as ulcerative colitis; it exerts local anti-inflammatory effects and results in low systemic exposure.

Cauloside C is a natural triterpenoid glycoside with anti-inflammatory activity, inhibiting iNOS and pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6, COX-2).

CAY10566 shows excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells (IC50=7.9 nM or 6.8 nM). CAY10566 is a potent, orally bioavailable and selective stearoyl

CB 300919 is a quinazoline-based antitumor agent exhibiting high activity against CH1 human ovarian tumor xenografts, with continuous exposure (96 h) resulting in a growth inhibition (IC50: 2 nM).

Fluvastatin-D6 sodium is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin sodium (TMSM-1236) is deuterium labeled Fluvastatin sodium.

Fluvastatin-D6 sodium is the deuterium-labeled analogue of Fluvastatin sodium. Fluvastatin sodium (T1487) (XU 62320) is the first fully synthetic and competitive HMG-CoA reductase inhibitor, with an IC50 of 8 nM.

Fluvastatin-D6 Sodium Salt is a deuterated compound of Fluvastatin Sodium Salt. Fluvastatin Sodium Salt (T1487) has a CAS number of 93957-55-2. Fluvastatin sodium, a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR), is a commonly used cholesterol lowering agent.